Liver metastasis is known to upregulate immune checkpoint molecules like PD-1 or PD-L1, which can induce systemic exhaustion of tumor-specific CD8+ T cells and attenuate immunotherapy efficacy [52]. This evidence concerns the gene CD8A and neoplasm.